Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Guang-Bi Yao"'
Autor:
Guang Bi YAO1 yaogb@yahoo.com.cn, Mei ZHU1, Zhen Yu CUI2, Bao En WANG3, Ji Lu YAO4, Ming de ZENG5
Publikováno v:
Journal of Digestive Diseases. May2009, Vol. 10 Issue 2, p131-137. 7p. 1 Diagram, 3 Charts, 2 Graphs.
Publikováno v:
Journal of Digestive Diseases. 10:131-137
To evaluate the long-term efficacy and safety of lamivudine treatment for chronic hepatitis B and the impact of emergence of YMDD mutation of hepatitis B virus (HBV).A total of 429 patients with serum HBsAg, HBeAg and HBV DNA positive were randomized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7199388b2896560fec909b04645067ef
https://doi.org/10.1111/j.1751-2980.2009.00375.x
https://doi.org/10.1111/j.1751-2980.2009.00375.x
Autor:
Stephen D. Gardner, Jules L. Dienstag, Zhen Yu Cui, Nancy R. Little, Nancy Leung, Anna S.F. Lok, Ching-Lung Lai, Dorothea A. Griffiths, Guang Bi Yao, Mary Castiglia, Eugene R. Schiff, E. Jenny Heathcote
Publikováno v:
Gastroenterology. 125:1714-1722
Data on the long-term safety of lamivudine are limited. The aim of this analysis was to determine the incidence of hepatitis flares, hepatic decompensation, and liver-disease-related (LDR) serious adverse events (SAE) during long-term lamivudine trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac1e4e94a11fde9b47f1c6aebb967503
https://doi.org/10.1053/j.gastro.2003.09.033
https://doi.org/10.1053/j.gastro.2003.09.033
Autor:
Yanyan Ji, Hong-Ying Pan, Yi-Qi Yu, Wenhong Zhang, Yue-Er Wang, Xiao-Wei Xu, Hong Wang, Jiali Wang, Shan-Min Wu, Jun Li, Xiu-Yun Ma, Erli Gu, Guang-Bi Yao, Qing Xie, Cheng-Wei Chen
Publikováno v:
World journal of gastroenterology. 21(2)
To observe the effect of response-guided add-on therapy with adefovir (ADV) and lamivudine (LAM) in cirrhotic hepatitis B (CHB) patients.A total of 100 patients with CHB and cirrhosis were divided into three arms according to hepatitis B virus (HBV)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51769fbe1e69c1edd60a6c0cb5a82c4d
https://pubmed.ncbi.nlm.nih.gov/25605989
https://pubmed.ncbi.nlm.nih.gov/25605989
Autor:
Guang-Bi Yao
Publikováno v:
Journal of Gastroenterology and Hepatology. 15:E61-E66
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66b7d3fc7f52fc4fb45558fa9fc7187e
https://doi.org/10.1046/j.1440-1746.2000.02106.x
https://doi.org/10.1046/j.1440-1746.2000.02106.x
Autor:
Guang Bi Yao
Publikováno v:
Journal of Medical Virology. 61:392-397
A randomised, multicentre, double-blind, placebo controlled trial was conducted in Chinese patients with chronic hepatitis B to compare the efficacy of once-daily lamivudine and placebo on serum HBV DNA, and to assess the long-term efficacy and safet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5944ef2dd699657cc0fc030da4b54435
https://doi.org/10.1002/1096-9071(200007)61:3<392::aid-jmv19>3.0.co
https://doi.org/10.1002/1096-9071(200007)61:3<392::aid-jmv19>3.0.co
Autor:
Guang-bi, Yao, Hong, Ren, Dao-zhen, Xu, Xia-qiu, Zhou, Ji-dong, Jia, Yu-ming, Wang, Cheng-wei, Chen
Publikováno v:
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 17(12)
To evaluate the virological, serological and biochemical outcomes of 3 years of entecavir (ETV) treatment in nucleoside-naive chronic hepatitis B patients.This study was divided into two stages: Patients receiving either ETV 0.5 mg/d (n = 258) or lam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ae4d0ce18d336ae540cfda313bc5aebe
https://pubmed.ncbi.nlm.nih.gov/20038326
https://pubmed.ncbi.nlm.nih.gov/20038326
Autor:
Er-li, Gu, Guang-bi, Yao
Publikováno v:
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 17(11)
To summarize the clinical features, diagnosis and treatment of patients with primary biliary cirrhosis (PBC) in China.Systematic analysis of clinical characteristics by searching the Chinese literatures.From 1955 to 2007, 2740 PBC patients were repor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::600136a69e202bb9a303173aed0c3f26
https://pubmed.ncbi.nlm.nih.gov/19958649
https://pubmed.ncbi.nlm.nih.gov/19958649
Autor:
Guang-bi, Yao, Mei, Zhu, Yu-ming, Wang, Dao-zhen, Xu, De-ming, Tan, Cheng-wei, Chen, Jin-lin, Hou
Publikováno v:
Zhonghua nei ke za zhi. 45(11)
This study was to evaluate the antiviral efficacy and safety in nucleoside naive Chinese patients with chronic hepatitis B (CHB) treated with entecavir (ETV) or lamivadine (LVD).The trial was a randomized, double-blind, double-dummy and control desig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1cd3a4baa408fa589def68872b8e1a6c
https://pubmed.ncbi.nlm.nih.gov/17313873
https://pubmed.ncbi.nlm.nih.gov/17313873
Autor:
Guang-Bi, Yao
Publikováno v:
Zhonghua nei ke za zhi. 45(11)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d0a837838a5c3b40bc56eb59cdd688ec
https://pubmed.ncbi.nlm.nih.gov/17313871
https://pubmed.ncbi.nlm.nih.gov/17313871